TradingKey

• HSBC shares rose on reassessed geopolitical and analyst sentiment. • JPMorgan, Morgan Stanley kept "Overweight" ratings on HSBC. • S&P revised outlook to "positive"; Erste raised EPS estimates.

• Novartis stock rose on positive del-brax trial results for FSHD. • Analysts maintained buy ratings and price targets, citing strong pipeline. • Novartis partnered with Orionis for molecular glue drug development.

• Broadcom offers to repurchase outstanding senior notes for debt optimization. • Strong AI semiconductor revenue growth fuels positive earnings outlook. • Analysts maintain "Buy" ratings, raising price targets on AI momentum.

Tradingkey - June 11: Global asset prices experienced intense volatility! The two major crude oil futures plummeted, while spot gold surged. The three major U.S. stock index futures strengthened in the short term, and U.S. Treasury yields dropped sharply. As of press time, WTI crude futures fell 3.72% to $86.68; Brent crude futures dropped 3.86% to $89.52. Spot gold rose approximately 2% to $4159. The three major U.S. stock index futures rose across the board, with Dow futures up 1.58%, Nasdaq 100 futures up 2.33%, and S&P 500 futures up 1.31%.

• Analysts upgraded Fortinet and raised price targets, boosting stock. • Fortinet reported strong Q1 2026 results and issued positive guidance. • New products and market expansions support Fortinet's growth strategy.

• Honeywell reaffirmed 2026 forecasts and set new three-year targets. • Aerospace spin-off aims to unlock shareholder value and streamline operations. • Analysts maintain positive sentiment with a majority of "Buy" ratings.

• Lockheed Martin secured nearly $10 billion in new defense awards. • New missile assembly building opened to support demand. • Analysts upgraded stock, citing valuations and sector tailwinds.

• Howmet Aerospace reported strong Q1 2026 earnings and revenue. • Analysts maintain positive ratings and increased price targets for HWM. • Institutional investors increased their holdings in Howmet Aerospace.

• SAP shares declined due to analyst, competitive, and macroeconomic pressures. • Goldman Sachs cut SAP's gross margin forecast due to anticipated hardware costs. • Oracle's high AI spending plans created sector-wide margin headwinds for SAP.

• CrowdStrike exceeded Q1 2027 revenue and EPS expectations. • Company recognized as leader in cloud/application runtime security. • Analysts maintain positive ratings; stock split announced.

• Inflation data and VIX surge indicate broader market risk-off sentiment. • S&P Global's positive company news is outweighed by market headwinds. • Technical indicators suggest neutral to oversold conditions for SPGI.

• Palo Alto Networks beat Q3 2026 earnings and revenue expectations. • Analysts issued buy ratings and raised price targets after earnings. • AI adoption drives demand for cybersecurity solutions like PANW.

• Analysts increase price targets citing AI memory demand. • Micron's 2026 HBM supply is reportedly sold out. • Bechtel selected for New York memory manufacturing complex.

• Gilead announced positive Phase 3 results for investigational HIV treatment islatravir/lenacapavir. • FDA granted priority review for bictegravir/lenacapavir HIV treatment application. • Phase 3 IDEAL study for Livdelzi in primary biliary cholangitis showed positive results.

• Amgen stock rose 3.35% driven by regulatory approval and trial data. • IMDYLLTRA received European Commission approval for small cell lung cancer. • Repatha trial data showed reduced cardiovascular events in diabetic patients.

• Shopify shares declined amid sector anxiety and valuation concerns. • Q2 guidance implied potential deceleration, raising cautious outlooks. • Platform transition risk and institutional selling pressure weigh.

• GE Vernova's share price increased due to positive analyst ratings and company fundamentals. • GEV raised its 2026 guidance for revenue, EBITDA margin, and free cash flow. • Electrification segment growth is driven by demand, industrialization, and AI data centers.

• Alibaba stock fell due to regulatory scrutiny over misleading advertising. • China's regulators are tightening oversight on internet giants, impacting competition. • Broader economic factors and strategic investments also pressure Alibaba's stock.

• Marvell joins S&P 500 Index June 22, 2026, driving mechanical buying. • AI infrastructure demand boosts Marvell, supported by Nvidia CEO comments. • Strong Q1 FY27 results and raised revenue forecasts underpin stock.

TradingKey - June 11: SpaceX is set to list on the Nasdaq. According to sources familiar with the matter, the largest IPO in SpaceX's history has attracted over $250 billion in investor subscription demand—3.5 to 4 times its planned $75 billion fundraising target—with market enthusiasm far exceeding expectations. The market is currently concerned that this record-breaking IPO will create a "liquidity drain" on the stock market, significantly diverting funds from the secondary market. This could, in turn, exert temporary valuation pressure on the storage and CPU sectors—the most popular AI trade segments for 2026—including core stocks such as Micron (MU), SanDisk (SNDK), Intel (INTC), and AMD (AMD).